Related Experiment Videos
Selective pigment medium for Streptococcus agalactiae
Abstract:
Increased awareness of the importance of Streptococcus agalactiae (Group B streptococcus) in neonatal morbidity and mortality has demonstrated the need for a selective and differential primary plating medium. In this report we describe a selective pigment medium containing colistin and nalidixic acid that allows presumptive identification of S. agalactiae from the primary plate, even when specimens are polymicrobic. A preliminary study compared the value of three media for pigment production by 137 known S. agalactiae strains. This was followed by a clinical laboratory trial using the best of these pigment media at an obstetric hospital in which 581 specimens from neonates, female reproductive tracts, and urinary tracts were screened. Subsequent to the clinical laboratory trial, an epidemiological investigation using the selective pigment medium was conducted on a mother/infant population. Of the 1,331 specimens screened for S. agalactiae, 75 (5.6%) were positive on 5% sheep blood agar and 79 (5.9%) were positive on the selective pigment medium.
Insights
A new selective pigment medium aids in identifying Streptococcus agalactiae (Group B Streptococcus). This medium is crucial for detecting the bacteria in neonatal samples, improving diagnostics for infant health.
Area of Science:
- Microbiology
- Clinical Diagnostics
- Neonatal Health
Background:
- Streptococcus agalactiae (Group B Streptococcus) poses significant risks for neonatal morbidity and mortality.
- Existing diagnostic methods require improvement for early and accurate detection.
Purpose of the Study:
- To develop and evaluate a selective and differential primary plating medium for Streptococcus agalactiae.
- To enable presumptive identification of S. agalactiae directly from polymicrobic specimens.
Main Methods:
- A selective pigment medium containing colistin and nalidixic acid was developed.
- Preliminary studies assessed pigment production by known S. agalactiae strains across three media.
- Clinical laboratory trials were conducted on specimens from neonates, female reproductive tracts, and urinary tracts.
- An epidemiological investigation was performed on a mother/infant population.
Main Results:
- The selective pigment medium demonstrated effectiveness in identifying S. agalactiae.
- In a clinical trial, 581 specimens were screened.
- An epidemiological study screened 1,331 specimens, with 5.6% positive on sheep blood agar and 5.9% on the selective pigment medium.
Conclusions:
- The novel selective pigment medium offers a valuable tool for the presumptive identification of Streptococcus agalactiae.
- This medium can be effectively used in clinical settings for screening various specimen types, including those from neonates.
- The development supports enhanced diagnostics for Group B Streptococcus, potentially reducing neonatal complications.